Role of residual insulin secretion in protecting against ketoacidosis in insulin-dependent diabetes

107Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

The role of preserved beta-cell function in preventing ketoacidosis in type I insulin-dependent diabetes was assessed in eight patients with and seven patients without residual beta-cell function as determined from C-peptide concentrations. After 12 hours of insulin deprivation blood glucose, ketone-body, non-esterified fatty-acid, and glycerol concentrations were all significantly higher in patients without beta-cell function than in those with residual secretion. Mean blood glucose concentrations reached 17.2±SE of mean 1.3 mmol/l (310 ±23 mg/100 ml) in the first group compared with 8.8±1.4 mmol/l (159±25 mg/100 ml) in the second (P<0.01), while 3-hydroxybutyrate concentrations rose to 5.5±0.5 mmol/l (57±5 mg/100 ml) and 1.4±0.3 mmol/l (15±3 mg/100 ml) in the two groups respectively (P<0.01). Individual mean C-peptide concentrations showed a significant inverse correlation with the final blood glucose values (r= −0.91; P<0.02). These findings strongly suggest that even minimal residual insulin secretion is important for metabolic wellbeing in diabetes and may prevent the development of severe ketoacidosis when insulin delivery is inadequate. © 1979, British Medical Journal Publishing Group. All rights reserved.

Cite

CITATION STYLE

APA

Madsbad, S., Binder, C., Faber, O. K., Krarup, T., Regeur, L., Alberti, K. G. M. M., & Burrin, J. M. (1979). Role of residual insulin secretion in protecting against ketoacidosis in insulin-dependent diabetes. British Medical Journal, 2(6200), 1257–1259. https://doi.org/10.1136/bmj.2.6200.1257

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free